Methylphenidate misuse in substance abusing adolescents

Journal of Child and Adolescent Substance Abuse

Volumn 9, Issue 3, 2000, Pages 1-14

  Marsh, Linda D ^a   Key, Janice D ^a   Payne, Tricia P ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Charleston County ^*  (United States)

Author keywords

Adolescents; Methylphenidate; Substance abuse

Indexed keywords

EID: 0034422122     PISSN: 1067828X     EISSN: 15470652     Source Type: Journal    
DOI: 10.1300/J029v09n03_01     Document Type: Article

References (40)

1. American Psychiatric Association. (1994. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
2. Adger, H. & Werner, M.J. (1996). The pediatrician. American Journal on Addictions, 5, 529-529.
3. Armentano, M.E. (1995). Assessment, diagnosis and treatment of the dually diagnosed adolescent. Pediatric Clinics of North America, 42, 479-490.
4. Bailey, R.A. & Hendren, R. L. (1997). A primer on adolescent psychopharmacology. Adolescent Medicine, 8, 33-55.
5. Barkley, R.A., McMurray, M.B., Edelbrock, C.S. & Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86, 184-192.
6. Biederman, J. & Steingard, R. (1989). Attention-deficit hyperactivity disorder in adolescents. Psychiatric Annals, 11, 587-596.
7. Biederman, J., Newcorr, J., & Sprich, S. (1991). Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. American Journal of Psychiatry, 148, 564-577.
8. Biederman, J., Wilens, T., Mick E., Milberger, S., Spencer, T.J. & Faraone, S.V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (AD/HD): effects of AD/HD and psychiatric comorbidity. American Journal of Psychiatry, 152, 1652-1658.
9. Biederman, J., Wilens, T., Mick, E, Faraone, S.V., Weber, W., Curtis, S., Thornell, A., Pfister, K., Jetton, J.G., & Soriano, J. (1997). Is AD/HD a risk factor for psychoactive substance use disorders? Findings from a four-year perspective follow-up study. Journal of the American Academy Child and Adolescent Psychiatry, 36, 21-29.
10. Bond, W.S. (1987). Recognition and treatment of attention deficit disorder. Clinical Pharmacy, 6, 617-624.
11. Bradley, C. (1937). The behavior of children receiving benzedrine. American Journal of Psychiatry, 94, 577-585.
12. Cantwell, D.P. & Baker, L. (1987). Differential diagnosis of hyperactivity. Journal of Developmental and Behavioral Pediatrics, 8, 159-165.
13. Chiarello, R.J. & Cole, J.O. (1987). The use of psychostimulants in general psychiatry. Archives of General Psychiatry, 44, 286-295.
14. Comerci, G.D. (1993). Office assessment of substance abuse and addiction. Adolescent Medicine, 4, 277-293.
15. Fulton, A.I. & Yates, W.R. (1988). Family abuse of methylphenidate. American Family Physician, 38, 143-145.
16. Gittleman, R., Mannuzza, S., Shenker, R. & Bonagura, N. (1985). Hyperactive boys almost grown up. Archives of General Psychiatry, 42, 937-947.
17. Goldenring, J.M. & Cohen, E.H. (1988). Getting into the adolescent’s H.E.A.D.S. Contemporary Pediatrics, 5, 75.
18. Goyer, P.F., Davis, G.C. & Rapoport, J.L. (1979). Abuse of prescribed stimulant medication by a 13-year-old hyperactive boy. Journal of the American Academy of Child Psychiatry, 18, 170-175.
19. Hack, S., & Jellineck, M. (1998). Early identification of emotional and behavioral problems in a primary care setting. Adolescent Medicine, 9(2), 335-350.
20. Hawkins, J.D. & Fitzgibbon, J.J. (1993). Risk factors and risk behaviors in prevention of adolescent substance abuse. Adolescent Medicine, 4, 249-262.
21. Horner, B.R. & Scheibe, K.E. (1997). Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. Journal of The American Academy of Child and Adolescent Psychiatry, 36, 30-36.
22. Jaffe, S.L. (1991). Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with AD/HD. Journal of The American Academy of Child Adolescent Psychiatry, 30, 773-775.
23. Klein, R.G. & Wender, P. (1995). The role ofmethylphenidate in psychiatry. Archives General Psychiatry, 52, 429-433.
24. Levy, H.B., Harper, C.R. & Weinberg, W.A. (1992). A practical approach to children failing In school. Pediatric Clinics of North America, 39, 895-928.
25. Morrison, M.A., Smith, D.E., Wilford, B.B., Ehrlick, P. & Seymour, R.B. (1993). At war in the fields of play: Current perspective on the nature and treatment of adolescent chemical dependency. Journal of Psychoactive Drugs, 25, 321-330.
26. Parran, T.V. & Jasinsk, D.R. (1991). Intravenous methylphenidate abuse: prototype for prescription drug abuse. Archives of Internal Medicine, 151, 781-783.
27. Perlmutter, S. (1995). Pharmacologic treatment of substance abuse. Child and Adolescent Psychiatric Clinics of North America, 4, 435-452.
28. Riggs, P.D., Thompson, L.L., Mikulich, S.K., et al. (1996). An open trial of pemoline in drug-dependent delinquentswith attention-deficit hyperactivity disorder. Journal of The America Academy of Child and Adolescent Psychiatry, 35, 1018-1024.
29. Robin, A.L. (1998). Attention deficit hyperactivity disorder. Adolescent Medicine, 9(2), 373-383.
30. Rosenberg, D.R., Holttum, J. & Gershon, S. (1994). Pharmacologic treatment of substance abuse disorders. In: Textbook for Pharmacotherapy for Child and Adolescent Disorders. New York: Brunner/Mazel, 408-510.
31. Rostain, A.L. (1997). Assessing and managing adolescents with school problems. Adolescent Medicine, 8, 57-76.
32. Safer, D.J. & Krager, J.M. (1992). Effect of a media blitz and a threatened lawsuit on stimulant treatment. Journal of American Medical Association, 268, 1004-1007.
33. Safer, D.J., Zito, J.M. & Fine, E.M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98, 1084-1088.
34. Schuydower, M., Fuller, PG., Heyman, R.B., Jacobs, E.A., Pruitt, A.W., Sutton, J.M. & Tenenbein, M. (1993). Role of the pediatrician in prevention and management of substance abuse. Pediatrics, 91, 1010-1013.
35. Spencer, T., Biederman, J., Wilens, T., Harding, M., O’Donnell, D. & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
36. Stowell, J.A. & Estroff, T.W. (1992). Psychiatric disorders in substance abusing adolescent inpatients: A pilot study. Journal of The American Academy of Child and Adolescent Psychiatry, 31, 1036-1040.
37. Volkow, N.D., Ding, Y.S., Fowler, J.S., Wang, D.J., Logan, J., Gatley, J.S., Dewey, S., Ashby, C., Lieberman, J., Hitzemann, R. & Wolf, A.P. (1995). Is methylphenidate like cocaine? Archives of General Psychiatry, 52, 456-463.
38. Weiss, G. (1985). Pharmacotherapy for ADD-H adolescents workshop. Psychopharmcology Bulletin, 21, 169-177.
39. Wilens, T.E. & Biederman, J. (1992). The stimulants. Psychiatric Clinics of North America, 15, 191-222.
40. Young, S.E., Mikulich, S.K., Goodwin, M.B., Hardy, J, Martin, C.L., Zoccolillo, M. & Crowley, T.J. (1995). Treated delinquent boys substance use: onset, pattern, relationship to conduct and mood disorders. Drug and Alcohol Dependence, 37, 149-162.